SCISPARC LTD (SPRC) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:SPRC • IL0010951403

0.7545 USD
-0.02 (-2.01%)
At close: Feb 3, 2026
0.76 USD
+0.01 (+0.73%)
Pre-Market: 2/4/2026, 8:35:18 AM
Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to SPRC. SPRC was compared to 191 industry peers in the Pharmaceuticals industry. SPRC has a bad profitability rating. Also its financial health evaluation is rather negative. SPRC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • SPRC had negative earnings in the past year.
  • In the past 5 years SPRC always reported negative net income.
  • In the past 5 years SPRC always reported negative operating cash flow.
SPRC Yearly Net Income VS EBIT VS OCF VS FCFSPRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • SPRC's Return On Assets of -122.18% is on the low side compared to the rest of the industry. SPRC is outperformed by 80.63% of its industry peers.
Industry RankSector Rank
ROA -122.18%
ROE N/A
ROIC N/A
ROA(3y)-44.59%
ROA(5y)-65.61%
ROE(3y)-61.5%
ROE(5y)-99.8%
ROIC(3y)N/A
ROIC(5y)N/A
SPRC Yearly ROA, ROE, ROICSPRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10K -20K -30K -40K

1.3 Margins

  • SPRC has a better Gross Margin (38.74%) than 61.26% of its industry peers.
  • The Profit Margin and Operating Margin are not available for SPRC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 38.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SPRC Yearly Profit, Operating, Gross MarginsSPRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

0

2. Health

2.1 Basic Checks

  • SPRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SPRC has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for SPRC has been increased compared to 5 years ago.
  • Compared to 1 year ago, SPRC has an improved debt to assets ratio.
SPRC Yearly Shares OutstandingSPRC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K 500K
SPRC Yearly Total Debt VS Total AssetsSPRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -23.48, we must say that SPRC is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -23.48, SPRC is doing worse than 85.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -23.48
ROIC/WACCN/A
WACC8.82%
SPRC Yearly LT Debt VS Equity VS FCFSPRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

  • A Current Ratio of 0.55 indicates that SPRC may have some problems paying its short term obligations.
  • The Current ratio of SPRC (0.55) is worse than 92.15% of its industry peers.
  • A Quick Ratio of 0.52 indicates that SPRC may have some problems paying its short term obligations.
  • SPRC's Quick ratio of 0.52 is on the low side compared to the rest of the industry. SPRC is outperformed by 89.53% of its industry peers.
Industry RankSector Rank
Current Ratio 0.55
Quick Ratio 0.52
SPRC Yearly Current Assets VS Current LiabilitesSPRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 91.42% over the past year.
  • SPRC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -54.64%.
EPS 1Y (TTM)91.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-54.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SPRC Yearly Revenue VS EstimatesSPRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M 2M 2.5M
SPRC Yearly EPS VS EstimatesSPRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • SPRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SPRC Price Earnings VS Forward Price EarningsSPRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SPRC Per share dataSPRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for SPRC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SCISPARC LTD

NASDAQ:SPRC (2/3/2026, 8:00:03 PM)

Premarket: 0.76 +0.01 (+0.73%)

0.7545

-0.02 (-2.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)04-24
Earnings (Next)N/A
Inst Owners0.24%
Inst Owner Change0%
Ins Owners26.3%
Ins Owner ChangeN/A
Market Cap2.47M
Revenue(TTM)1.31M
Net Income(TTM)-6.28M
AnalystsN/A
Price TargetN/A
Short Float %12.26%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.89
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-22.63
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.4
BVpS-0.24
TBVpS-0.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -122.18%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 38.74%
FCFM N/A
ROA(3y)-44.59%
ROA(5y)-65.61%
ROE(3y)-61.5%
ROE(5y)-99.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.55
Quick Ratio 0.52
Altman-Z -23.48
F-ScoreN/A
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.64%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.41%
OCF growth 3YN/A
OCF growth 5YN/A

SCISPARC LTD / SPRC FAQ

Can you provide the ChartMill fundamental rating for SCISPARC LTD?

ChartMill assigns a fundamental rating of 0 / 10 to SPRC.


What is the valuation status of SCISPARC LTD (SPRC) stock?

ChartMill assigns a valuation rating of 0 / 10 to SCISPARC LTD (SPRC). This can be considered as Overvalued.


How profitable is SCISPARC LTD (SPRC) stock?

SCISPARC LTD (SPRC) has a profitability rating of 1 / 10.